• Published On: January 20, 2022

    Regular use of ivermectin as a prophylactic was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates. The results are in from the world’s largest study of ivermectin for COVID-19.

  • Published On: January 11, 2022

    Writing in The New American, Selwyn Duke says many people find it shocking to learn that two years into the pandemic there are still no official treatment protocols for COVID-19.

  • Published On: December 20, 2021

    After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials. Areas of Uncertainty: The majority of trialed agents have failed to provide reproducible, definitive proof of efficacy in reducing the mortality of COVID-19 with the exception of corticosteroids in moderate to severe disease. Recently, evidence has emerged that the oral antiparasitic agent ivermectin exhibits numerous antiviral and anti-inflammatory mechanisms with trial results reporting significant outcome benefits. Given some have not passed peer review, several expert groups including Unitaid/World Health Organization have undertaken a systematic global effort to contact all active trial investigators to rapidly gather the data needed to grade and perform meta-analyses. Data Sources: Data were sourced from published peer-reviewed studies, manuscripts posted to preprint servers, expert meta-analyses, and numerous epidemiological analyses of regions with ivermectin distribution campaigns. Therapeutic Advances: A large majority of randomized and observational controlled trials of ivermectin are reporting repeated, large magnitude improvements in clinical outcomes. Numerous prophylaxis trials demonstrate that regular ivermectin use leads to large reductions in transmission. Multiple, large “natural experiments” occurred in regions that initiated “ivermectin distribution” campaigns followed by tight, reproducible, temporally associated decreases in case counts and case fatality rates compared with nearby regions without such campaigns. Conclusions: Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.

  • Published On: December 8, 2021

    Nebraska’s Attorney General issued an opinion on the “Prescription of Ivermectin and Hydroxychloroquine as Off-Label Medicines for the Prevention or Treatment of Covid-19.

  • Published On: November 2, 2021

    "Does Ivermectin save lives? Absolutely. Does it alleviate suffering? Yes. Does it prevent deaths? Absolutely. And we cannot be silenced. We must speak for those who have no voice. Patients have a right to seek life saving care, and we should make this available to patients who want it."

  • Published On: October 16, 2021

    In "Horse-Bleep: How 4 Calls on Animal Ivermectin Launched a False FDA-Media Attack," investigative reporters Pfeiffer and Bonvie dug up FDA emails documenting the start of the coordinated, mass propaganda campaign against IVM — and got The New York Times to correct its false reporting about it.

  • Published On: October 15, 2021

    Remdesivir is (at best) useless against Covid-19. At worst, it is dangerous to patients who receive it.

  • Published On: October 14, 2021

    Authors: Peterson DJ. PMID: Abstract Keywords: Source: https://ago.nebraska.gov/sites/ago.nebraska.gov/files/docs/opinions/21-017_0.pdf Archive: https://archive.is/EoVhB

  • Published On: October 14, 2021

    TrialSite News provides clip of The Joe Rogan Experience where Dr. Sanjay Gupta admits CNN lied about ivermectin in horse deworming smear.

  • Published On: October 13, 2021

    This TrialSiteNews investigation, reprinted with permission on the BIRD Group blog, describes the smear campaign launched by governmental regulatory bodies, mainstream media, and disinformation agents/fact-checkers against ivermectin.